Literature DB >> 35091964

Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?

Marta Molina Romero1, Alberto Yoldi Chaure2, Miguel Gañán Parra3, Purificación Navas Bastida4, José Luis Del Pico Sánchez2, Ángel Vaquero Argüelles2, Paloma de la Fuente Vaquero3, Juan Pablo Ramírez López2, José Antonio Castilla Alcalá2,5,6.   

Abstract

PURPOSE: To estimate the probability of high-risk genetic matching when assisted reproductive techniques (ART) are applied with double gamete donation, following an NGS carrier test based on a complete study of the genes concerned. We then determine the results that would have been obtained if the genotyping tests most widely used in Spanish gamete banks had been applied.
METHODS: In this descriptive observational study, 1818 gamete donors were characterised by NGS. The pathogenic variants detected were analysed to estimate the probability of high-risk genetic matching and to determine the results that would have been obtained if the three most commonly used genotyping tests in ART had been applied.
RESULTS: The probability of high-risk genetic matching with gamete donation, screened by NGS and complete gene analysis, was 5.5%, versus the 0.6-2.7% that would have been obtained with the genotyping test. A total of 1741 variants were detected, including 607 different variants, of which only 22.6% would have been detected by all three genotyping tests considered and 44.7% of which would not have been detected by any of these tests.
CONCLUSION: Our study highlights the considerable heterogeneity of the genotyping tests, which present significant differences in their ability to detect pathogenic variants. The complete study of the genes by NGS considerably reduces reproductive risks when genetic matching is performed with gamete donors. Accordingly, we recommend that carrier screening in gamete donors be carried out using NGS and a complete study with nontargeted analysis of the variants of the screened genes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Carrier screening; Gamete donors; Genetic matching; Genotyping test; Next-generation sequencing; Recessive disease

Mesh:

Year:  2022        PMID: 35091964      PMCID: PMC8956772          DOI: 10.1007/s10815-021-02381-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  232 in total

1.  The spectrum of mutations and molecular pathogenesis of hemophilia A in 181 Portuguese patients.

Authors:  Dezsö David; Célia Ventura; Isabel Moreira; Maria J Diniz; Margarida Antunes; Alice Tavares; Fernando Araújo; Sara Morais; Manuel Campos; João Lavinha; Geoffrey Kemball-Cook
Journal:  Haematologica       Date:  2006-06       Impact factor: 9.941

2.  An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis.

Authors:  Liangjing Chen; Andrew Hadd; Sachin Sah; Stela Filipovic-Sadic; Julie Krosting; Edward Sekinger; Ruiqin Pan; Paul J Hagerman; Timothy T Stenzel; Flora Tassone; Gary J Latham
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

3.  Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology.

Authors:  Julio Martin; Yuting Yi; Trinidad Alberola; Beatriz Rodríguez-Iglesias; Jorge Jiménez-Almazán; Qin Li; Huiqian Du; Pilar Alama; Amparo Ruiz; Ernesto Bosch; Nicolas Garrido; Carlos Simon
Journal:  Fertil Steril       Date:  2015-09-03       Impact factor: 7.329

4.  Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements.

Authors:  Feng Wang; Hui Wang; Han-Fang Tuan; Duy H Nguyen; Vincent Sun; Vafa Keser; Sara J Bowne; Lori S Sullivan; Hongrong Luo; Ling Zhao; Xia Wang; Jacques E Zaneveld; Jason S Salvo; Sorath Siddiqui; Louise Mao; Dianna K Wheaton; David G Birch; Kari E Branham; John R Heckenlively; Cindy Wen; Ken Flagg; Henry Ferreyra; Jacqueline Pei; Ayesha Khan; Huanan Ren; Keqing Wang; Irma Lopez; Raheel Qamar; Juan C Zenteno; Raul Ayala-Ramirez; Beatriz Buentello-Volante; Qing Fu; David A Simpson; Yumei Li; Ruifang Sui; Giuliana Silvestri; Stephen P Daiger; Robert K Koenekoop; Kang Zhang; Rui Chen
Journal:  Hum Genet       Date:  2013-10-24       Impact factor: 4.132

5.  Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins.

Authors:  A Adato; D Weil; H Kalinski; Y Pel-Or; H Ayadi; C Petit; M Korostishevsky; B Bonne-Tamir
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

6.  Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France.

Authors:  M Claustres; C Guittard; D Bozon; F Chevalier; C Verlingue; C Ferec; E Girodon; C Cazeneuve; T Bienvenu; G Lalau; V Dumur; D Feldmann; E Bieth; M Blayau; C Clavel; I Creveaux; M C Malinge; N Monnier; P Malzac; H Mittre; J C Chomel; J P Bonnefont; A Iron; M Chery; M D Georges
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

7.  Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.

Authors:  Sumit Punj; Yassmine Akkari; Jennifer Huang; Fei Yang; Allison Creason; Christine Pak; Amiee Potter; Michael O Dorschner; Deborah A Nickerson; Peggy D Robertson; Gail P Jarvik; Laura M Amendola; Jennifer Schleit; Dana Kostiner Simpson; Alan F Rope; Jacob Reiss; Tia Kauffman; Marian J Gilmore; Patricia Himes; Benjamin Wilfond; Katrina A B Goddard; C Sue Richards
Journal:  Am J Hum Genet       Date:  2018-05-10       Impact factor: 11.025

8.  High frequency of the R75Q CFTR variation in patients with chronic obstructive pulmonary disease.

Authors:  Aleksandra Divac; Aleksandra Nikolic; Marija Mitic-Milikic; Ljudmila Nagorni-Obradovic; Natasa Petrovic-Stanojevic; Vesna Dopudja-Pantic; Ruzica Nadaskic; Ana Savic; Dragica Radojkovic
Journal:  J Cyst Fibros       Date:  2004-08       Impact factor: 5.482

9.  Analysis of the CTNS gene in nephropathic cystinosis Mexican patients: report of four novel mutations and identification of a false positive 57-kb deletion genotype with LDM-2/exon 4 multiplex PCR assay.

Authors:  Miguel Angel Alcántara-Ortigoza; Leticia Belmont-Martínez; Marcela Vela-Amieva; Ariadna González-Del Angel
Journal:  Genet Test       Date:  2008-09

10.  Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome.

Authors:  Peter M Krawitz; Daniela Schiska; Ulrike Krüger; Sandra Appelt; Verena Heinrich; Dmitri Parkhomchuk; Bernd Timmermann; Jose M Millan; Peter N Robinson; Stefan Mundlos; Jochen Hecht; Manfred Gross
Journal:  Mol Genet Genomic Med       Date:  2014-06-15       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.